Catalog #: K210221 (210221)
For in vitro diagnostic use.
Biopool TintElize® PAI-1 is an enzyme immunoassay (ELISA) for the quantitative determination of human plasminogen activator inhibitor, type 1 (PAI-1) antigen in human plasma.
Summary
Plasminogen activator inhibitor; type 1 (PAI-1) is the primary inhibitor of tissue plasminogen activator (tPA), a key enzyme in fibrinolysis. An increased plasma level of PAI-1 is associated with impaired fibrinolytic function. Elevated levels of PAI-1 have been observed in thrombolytic disease, acute myocardial infarction, deep vein thrombosis, as well as normal pregnancy and sepsis. PAI-1 is produced by vascular endothelial cells, platelets, placenta, and kidney tubule cells. PAI-1 is found in several forms: active, inactive (latent) and complexed to tPA and uPA, all of which are measured in the TintElize PAI-1 assay.
Principle
The Biopool TintElize PAI-1 test is based on a double antibody principle, similar to the ELISA described by Declerck et al. and uses the same coating antibody (MA-7D4B7). The assay uses quenching and normal antibodies to exclude falsely elevated results from the specific response, a limitation of conventional ELISA assay. This method to obtain specific ELISA is "ISAC" (Immunological Specificity and Accuracy Control; patented).
The A-wells (green in colour) contain monoclonal antibodies against PAI-1 immobilized onto the well surface as well as soluble antibodies against PAI-1. The N-wells (blue in colour) contain the same monoclonal antibodies against PAI-1 immobilized onto the well surface and soluble non-immune antibodies. During sample incubation, the PAI-1 antigen in the sample is quantitatively bound to antibodies coating the N-wells, but not the A-wells (prevented from binding by the soluble anti-PAI-1 antibodies). HRP-conjugated anti-PAI-1 antibodies are added and will also bind to the PAI-1 molecule. This forms a sandwich of coating antibody: PAI-1: conjugate antibody. The wells are washed to remove excess conjugate and other unbound material. The HRP substrate (OPD/H2O2) is added and converted to the yellow-coloured product at a rate proportional to the amount of HRP-conjugate bound. The difference in response between the N-well and the A-well is the specific PAI-1 response.
Reagent -- Composition, Packaging, Storage and Stability
The unreconstituted reagents are stable until the expiry date indicated on the label when stored at 2-8 °C.
Additional Materials Required (but not provided):
Cleared: FDA, Canadian Licensed
| Name | Type | Size |
|---|---|---|
| Biopool Fibrinolysis Flyer | application/pdf | 608.65 kB |
| PAI & tPA Kit Comparison Sheet | application/pdf | 30.55 kB |
| TintElize PAI-1 Declaration of Conformity | application/pdf | 22.93 kB |
| TintElize PAI-1 Package Insert | application/pdf | 28.96 kB |